Virtu Financial LLC Igm Biosciences, Inc. Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 17, 2022
SELL
$27.59 - $66.39 $203,917 - $490,688
-7,391 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$65.76 - $90.65 $486,032 - $669,994
7,391 New
7,391 $486,000
Q3 2020

Dec 11, 2020
SELL
$43.0 - $84.01 $182,105 - $355,782
-4,235 Closed
0 $0
Q2 2020

Aug 07, 2020
BUY
$51.3 - $75.21 $217,255 - $318,514
4,235 New
4,235 $309,000

Others Institutions Holding IGMS

# of Institutions
89
Shares Held
21.4M
Call Options Held
39.5K
Put Options Held
16.5K
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email